Is baseline TAPSE/PASP ratio associated with all-cause mortality in patients undergoing TAVI?
Incorporating the TAPSE/PASP ratio into risk stratification may improve patient selection for TAVI by evaluating RV systolic performance against afterload.
Baseline TAPSE/PASP ratio is associated with all-cause mortality in TAVI patients as it evaluates RV systolic performance at a given degree of afterload. Incorporation of right-side unit into the risk stratification may improve optimal selection of patients for TAVI.
Sultan et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: